In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Story of the Stent: An Interview with Julio Palmaz

Executive Summary

Arguably the most important medical device launched in the last two decades, coronary stents have a fascinating history, filled with stories of unappreciated potential and developmental missteps. In Vivo interviews the stent's inventor, Julio Palmaz, about the vicissitudes of stents.

You may also be interested in...



Two Physicians' Views from the Device Innovator's Workbench

Interviews with physician/entrepreneurs Michael Lesh, who launched Atrionix, and William New, Jr., founder of Nellcor, discussing moviemaking and the Zen of device start-ups.

More from the Device Innovators' Workbench

Interviews with medical device inventors/entrepreneurs Rodney Perkins, MD, and Mir Imran, discussing their successes, such as Collagen and PercuSurge, and the ones that didn't make it.

Mylan And Lupin Prepare To Launch EU Etanercept

Mylan and Lupin have revealed when they expect to launch their etanercept biosimilar, Nepexto, in Europe after receiving formal European Commission approval.

Topics

Related Companies

UsernamePublicRestriction

Register

MT065510

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel